|
CCAR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.414400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.791400E-01 |
| Normal-vs-Stage2 |
8.379200E-01 |
| Normal-vs-Stage3 |
5.831600E-01 |
| Normal-vs-Stage4 |
3.763200E-01 |
| Stage1-vs-Stage2 |
8.834400E-01 |
| Stage1-vs-Stage3 |
9.401200E-01 |
| Stage1-vs-Stage4 |
6.914400E-01 |
| Stage2-vs-Stage3 |
8.610400E-01 |
| Stage2-vs-Stage4 |
7.110800E-01 |
| Stage3-vs-Stage4 |
8.314600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.793000E-01 |
| Normal-vs-AfricanAmerican |
9.495000E-01 |
| Normal-vs-Asian |
4.408400E-01 |
| Caucasian-vs-AfricanAmerican |
6.189400E-01 |
| Caucasian-vs-Asian |
5.165400E-01 |
| AfricanAmerican-vs-Asian |
6.451800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.426200E-01 |
| Normal-vs-Female |
2.385000E-01 |
| Male-vs-Female |
1.615590E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.689600E-01 |
| Normal-vs-Extreme_Weight |
1.024390E-01 |
| Normal-vs-Obese |
9.161200E-01 |
| Normal-vs-Extreme_Obese |
4.475200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.621800E-01 |
| Normal_Weight-vs-Obese |
6.358000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.486000E-01 |
| Extreme_Weight-vs-Obese |
1.580780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.191400E-01 |
| Obese-vs-Extreme_Obese |
6.030000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.635900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.917400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.039800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.379600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.860800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.475700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.475900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.500900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.862000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.567760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.915800E-01 |
| Normal-VS-Type2 PRCC |
2.118800E-03 |
| Normal-VS-KIRP CIMP |
8.057000E-01 |
| Normal-VS-Unclassified PRCC |
9.477000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.442890E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.112000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.676200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.682760E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.725900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.885600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.742200E-02 |
| Normal-vs-N1 |
2.853600E-01 |
| Normal-vs-N2 |
6.068000E-02 |
| N0-vs-N1 |
8.724100E-03 |
| N0-vs-N2 |
4.931400E-01 |
| N1-vs-N2 |
1.131430E-01 |
|
|
